Viewing Study NCT02046369


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-02-20 @ 8:15 PM
Study NCT ID: NCT02046369
Status: COMPLETED
Last Update Posted: 2017-12-20
First Post: 2014-01-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Lurasidone Pediatric Bipolar Study
Sponsor: Sumitomo Pharma America, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: D1050326
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators